Bio-Rad Laboratories | BIO - Ebitda


Bio-Rad Laboratories reported $-374.6M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Agilent USD 540M 74M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio Techne USD 103.42M 7.47M Dec/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
Bruker USD 211.6M 207.4M Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Danaher USD 2.13B 252M Dec/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Illumina USD 332M 12M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
Merck USD 8.39B 1.97B Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quest Diagnostics USD 537M 24M Dec/2025
Repligen USD 39.54M 3.61M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.64B 535M Dec/2025
Standard Biotools USD -15.81M 734K Dec/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Tosoh JPY 39.13B 286M Dec/2024
Waters USD 380.97M 85.83M Dec/2025